Australians should visit their pharmacist to prepare for PBS medicine changes taking effect from January 1, 2016, Australia’s peak pharmacist organisation, the Pharmaceutical Society of Australia (PSA) said.
php echo wp_list_categories(); ?>
December 23, 2015
Australians should visit their pharmacist to prepare for PBS medicine changes taking effect from January 1, 2016, Australia’s peak pharmacist organisation, the Pharmaceutical Society of Australia (PSA) said.
Under the changes, 17 types of over-the-counter medicines, including paracetamol and aspirin, will be delisted from the Pharmaceutical Benefits Scheme (PBS).
PSA National President Joe Demarte said patients with chronic conditions who normally accessed medication through a PBS prescription will be affected.
“If people have been taking over-the-counter medicines on prescription for osteoarthritis, headaches and heartburn or have suffered a stroke, they should urgently consult their pharmacist,” Mr Demarte said.
“It’s vital for these patients to contact their pharmacist or prescriber to ensure they’re aware of all medication options for managing their condition. This is critical as in some cases the quantity and formulation of certain medicines – for example, Panadol Osteo – are not easily available.
“Pharmacists know from previous experience that changes to PBS rules can cause confusion for patients and carers, especially during the Christmas holiday period.”
The PBS delistings were announced by Federal Health Minister Sussan Ley in November this year following advice and consultation by the independent Pharmaceutical Benefits Advisory Committee (PBAC).
Over-the-counter medicines for certain conditions will no longer be subsidised on prescription under the PBS from January 1 as part of savings measures.
“The PSA is committed to ensuring patients’ health needs are being met and assisting Government progress savings measures to ensure the sustainability of the PBS,” Mr Demarte said.
Add new comment